BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36929436)

  • 21. Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.
    Holtan SG; Shabaneh A; Betts BC; Rashidi A; MacMillan ML; Ustun C; Amin K; Vaughn BP; Howard J; Khoruts A; Arora M; DeFor TE; Johnson D; Blazar BR; Weisdorf DJ; Wang J
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease.
    Zhu F; Qiao J; Chen W; Pan B; Wu QY; Cao J; Sang W; Yan ZL; Zeng LY; Li ZY; Xu KL
    Ann Hematol; 2015 Jun; 94(6):1025-32. PubMed ID: 25623380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
    Chaidos A; Patterson S; Szydlo R; Chaudhry MS; Dazzi F; Kanfer E; McDonald D; Marin D; Milojkovic D; Pavlu J; Davis J; Rahemtulla A; Rezvani K; Goldman J; Roberts I; Apperley J; Karadimitris A
    Blood; 2012 May; 119(21):5030-6. PubMed ID: 22371885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunobiology of acute graft-versus-host disease.
    Renkonen R
    Med Biol; 1987; 65(5-6):241-8. PubMed ID: 3330170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
    Chen YB; Kim HT; McDonough S; Odze RD; Yao X; Lazo-Kallanian S; Spitzer TR; Soiffer R; Antin JH; Ritz J
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1066-76. PubMed ID: 19660719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
    Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
    Front Immunol; 2021; 12():692225. PubMed ID: 34220852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
    Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
    Front Immunol; 2021; 12():687961. PubMed ID: 34335589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantation.
    Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
    Pediatr Transplant; 2020 Nov; 24(7):e13793. PubMed ID: 32741088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
    Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
    Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E
    Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling Tissue and Biofluid miR-155-5p, miR-155
    Crossland RE; Norden J; Ghimire S; Juric MK; Pearce KF; Lendrem C; Collin M; Mischak-Weissinger E; Holler E; Greinix HT; Dickinson AM
    Front Immunol; 2021; 12():639171. PubMed ID: 33790910
    [No Abstract]   [Full Text] [Related]  

  • 35. Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation.
    Ngoma AM; Ikeda K; Hashimoto Y; Mochizuki K; Takahashi H; Sano H; Matsumoto H; Noji H; Saito S; Kikuta A; Ogawa K; Ohtsuka M; Abe M; Nollet KE; Ohto H
    Int J Hematol; 2012 Jan; 95(1):86-94. PubMed ID: 22160825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. R707, a fully human antibody directed against CC-chemokine receptor 7, attenuates xenogeneic acute graft-versus-host disease.
    Fowler KA; Vasilieva V; Ivanova E; Rimkevich O; Sokolov A; Abbasova S; Kim E; Coghill JM
    Am J Transplant; 2019 Jul; 19(7):1941-1954. PubMed ID: 30748092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant donor CD4
    Rubio MT; Bouillié M; Bouazza N; Coman T; Trebeden-Nègre H; Gomez A; Suarez F; Sibon D; Brignier A; Paubelle E; Nguyen-Khoc S; Cavazzana M; Lantz O; Mohty M; Urien S; Hermine O
    Leukemia; 2017 Apr; 31(4):903-912. PubMed ID: 27740636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute graft-versus-host disease.
    Bolaños-Meade J; Vogelsang GB
    Clin Adv Hematol Oncol; 2004 Oct; 2(10):672-82. PubMed ID: 16163254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.